Pichia qpcr residual host cell DNA partial validation, GMP; and, pichia qpcr residual host cell DNA by extraction, GMP

Ended Purchase Order Awarded Last action

Contract number
75N93021P00504
Awardee
Awarding agency
Obligated
$23,000

Award facts

Contract value 100% obligated
$23,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Houston, TX 77040, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 · To administratively DE-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 -$50
Original award $23,050

About this award

Written by GovTribe AI ·

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Avance Biosciences Inc. for $23,000 on April 1, 2021. The order covers Pichia QPCR residual host cell DNA partial validation and extraction testing under GMP conditions. Work is performed in Houston, Texas. The order was issued to de-obligate expiring fiscal year 2021 funding by the September 30, 2021 period-of-availability closing date.

Quick answers

Who was awarded contract 75N93021P00504?

75N93021P00504 was awarded to Avance Biosciences Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 1, 2021.

How much is contract 75N93021P00504 worth?

The government has obligated $23,000 on 75N93021P00504.

Was contract 75N93021P00504 competed?

The extent of competition for 75N93021P00504 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login